Literature DB >> 10541473

Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay?

K Matsumura1, F Saito, H Yamada, A Hase, Y Sunada, T Shimizu.   

Abstract

In striated muscle, the cytoskeletal protein dystrophin, the protein product of the Duchenne muscular dystrophy gene, is associated with a number of sarcolemmal glycoproteins to form a large oligomeric complex, the dystrophin-glycoprotein complex (DGC). Over the last 10 years, four of these sarcolemmal glycoproteins, alpha-, beta-, gamma- and delta-sarcoglycans, have been shown to form a distinct subcomplex, the sarcoglycan complex, in the DGC. Furthermore, the genetic defects of alpha-, beta-, gamma- and delta-sarcoglycans have been identified as the causes of four distinct forms of muscular dystrophies, which are now collectively called sarcoglycanopathy. Current studies are beginning to focus on the biological functions of the sarcoglycan complex and the molecular mechanism by which its dysfunction leads to muscle cell degeneration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541473

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  6 in total

1.  Sarcoglycan, the heart, and skeletal muscles: new treatment, old drug?

Authors:  J A Towbin; N E Bowles
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  Ultrastructural definition of apoptosis in heart failure.

Authors:  Eloisa Arbustini; Agnese Brega; Jagat Narula
Journal:  Heart Fail Rev       Date:  2008-06       Impact factor: 4.214

3.  In vivo regulation of human skeletal muscle gene expression by thyroid hormone.

Authors:  Karine Clément; Nathalie Viguerie; Maximilian Diehn; Ash Alizadeh; Pierre Barbe; Claire Thalamas; John D Storey; Patrick O Brown; Greg S Barsh; Dominique Langin
Journal:  Genome Res       Date:  2002-02       Impact factor: 9.043

4.  Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy.

Authors:  S Tsubata; K R Bowles; M Vatta; C Zintz; J Titus; L Muhonen; N E Bowles; J A Towbin
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

5.  Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse.

Authors:  C J Mann; K Honeyman; A J Cheng; T Ly; F Lloyd; S Fletcher; J E Morgan; T A Partridge; S D Wilton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

6.  δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.

Authors:  Alison M Blain; Volker W Straub
Journal:  Skelet Muscle       Date:  2011-03-17       Impact factor: 4.912

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.